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ABSTRACT Studies in patients have suggested that the clinical phenotypes of some mitochondrial
diseases might transit from one disease to another (e.g., Pearson syndrome [PS] to Kearns-Sayre syndrome)
in single individuals carrying mitochondrial (mt) DNA with a common deletion (ΔmtDNA), but there is no
direct experimental evidence for this. To determine whether ΔmtDNA has the pathologic potential to
induce multiple mitochondrial disease phenotypes, we used trans-mitochondrial mice with a heteroplasmic
state of wild-type mtDNA and ΔmtDNA (mito-miceΔ). Late-stage embryos carrying $50% ΔmtDNA showed
abnormal hematopoiesis and iron metabolism in livers that were partly similar to PS (PS-like phenotypes),
although they did not express sideroblastic anemia that is a typical symptom of PS. More than half of the
neonates with PS-like phenotypes died by 1 month after birth, whereas the rest showed a decrease of
ΔmtDNA load in the affected tissues, peripheral blood and liver, and they recovered from PS-like pheno-
types. The proportion of ΔmtDNA in various tissues of the surviving mito-miceΔ increased with time, and
Kearns-Sayre syndrome2like phenotypes were expressed when the proportion of ΔmtDNA in various
tissues reached .70–80%. Our model mouse study clearly showed that a single ΔmtDNA was responsible
for at least two distinct disease phenotypes at different ages and suggested that the level and dynamics of
ΔmtDNA load in affected tissues would be important for the onset and transition of mitochondrial disease
phenotypes in mice.
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Pathogenic mtDNAs having a large-scale deletion (ΔmtDNA), called
the “common deletion,” or a point mutation, induce defects of mito-
chondrial oxidative phosphorylation (mitochondrial respiration de-
fects) and manifest as a wide variety of mitochondrial diseases
(Larsson and Clayton 1995; Wallace 1999). It has been well docu-
mented that ΔmtDNA is responsible for three clinical phenotypes of
mitochondrial diseases: Kearns–Sayre syndrome (KSS), progressive
external ophthalmoplegia, and Pearson syndrome (PS) (DiMauro
and Garone 2011). KSS is usually sporadic and is characterized by
early onset (,20 years of age), lactic acidosis, chronic progressive
external ophthalmoplegia, pigmentary retinopathy, heart block, dia-
betes, deafness, cerebellar abnormalities, and renal failure. Progressive
external ophthalmoplegia is mainly a skeletal muscle disorder and is
characterized by late-onset progressive external ophthalmoplegia, lac-
tic acidosis, myopathy, and exercise intolerance. PS is a rare disorder
of early infancy that is characterized mainly by sideroblastic anemia.
At present, the precise mechanism by which ΔmtDNA can cause
different disease phenotypes is unclear, although it has been consid-
ered that different loads of ΔmtDNA in tissues are important to
establish the multiple disease phenotypes.
Some studies in patients have reported the possibility that infants
with PS who survive into childhood develop the clinical features
of KSS (Larsson et al. 1990; McShane et al. 1991; Rotig et al.
1995). Furthermore, Larsson et al. (1990) suggest that the transition
of disease phenotypes is governed by the fractional concentration of
ΔmtDNA in various tissues; however, there is currently no experimental
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evidence for this. Because mitochondrial function is regulated both by
nuclear DNA and mtDNA (Larsson and Clayton 1995), it is possible
that nuclear genomic background is involved in the pathogenesis of
different disease phenotypes. Supporting this hypothesis is the ﬁnding
that the homoplasmic state of a pathogenic mutant mtDNA does not
always induce serious clinical phenotypes in a mother and her children
(McFarland et al. 2002).
Here, to experimentally resolve the question of whether mitochon-
drial disease phenotypes can change in single individuals as a result of
the dynamics of the proportion of ΔmtDNA in various tissues, we have
used a mouse model carrying pathogenic ΔmtDNA. Previously, we
succeeded in generating a trans-mitochondrial mouse model (mito-
miceΔ) with a heteroplasmic state for wild-type mtDNA and ΔmtDNA
with a 4696-bp deletion from nucleotide position 7759 of the tRNALys
gene to position 12,454 of the ND5 gene (see Figure 1A) (Inoue et al.
2000). The ΔmtDNA introduced in mito-miceΔ is similar to the path-
ogenic mutant mtDNA with the “common deletion” that is found in
patients with KSS or PS (Holt et al. 1988; Larsson et al. 1990; McShane
et al. 1991; Rotig et al. 1995). Because the mito-miceΔ all share the
same nuclear genomic background (C57BL/6, also called B6), their
genetic variation is restricted to the load of ΔmtDNA in various tissues.
The mito-miceΔ, therefore, would provide the direct experiment evi-
dence whether a single ΔmtDNA could cause the onset and transition
of different mitochondrial disease phenotypes.
By using these mito-miceΔ, we investigated that ΔmtDNA pos-
sessed a pathogenic potential for the onset of two distinct phenotypes
of mitochondrial diseases, PS-like and KSS-like phenotypes, early in
life (days 1234 after birth) and in midlife (6 months of age), respec-
tively. We also observed that the mice that escaped from the early
death probably because PS-like phenotypes developed KSS-like phe-
notypes in middle age, showing the transition of distinct mitochon-
drial disease phenotypes in single mito-miceΔ.
MATERIALS AND METHODS
Mice
Mito-miceΔ were generated by introducing ΔmtDNA from cultivated
cells into the zygotes of B6 strain mice by using cell fusion techniques,
as described previously (Inoue et al. 2000). Thirty-three female mito-
miceΔ carrying 1–63% ΔmtDNA at 2–6 months of age were used as
mothers. Embryos on E18.5 and progeny were used for the study.
Age-matched wild-type B6 mice were used as normal controls. All
animal experiments were performed in compliance with the institu-
tional guidelines of the University of Tsukuba for the care and use of
laboratory animals.
Estimation of DmtDNA proportion in tissues
Proportions of wild-type mtDNA and ΔmtDNA were determined by
using real-time polymerase chain reaction, as described previously
(Sato et al. 2005). Tail samples were used to deduce the ΔmtDNA
load in mito-miceΔ. The proportion of ΔmtDNA was also examined
in various tissue samples (peripheral blood, liver, kidney, and eye).
Figure 1 Gene map of ΔmtDNA
introduced in mito-miceΔ and
observations of mito-miceΔ on
the early life. (A) A wild-type
mtDNA (left) is a circular DNA
(16.3 kbp) and encodes 37 genes,
including 13 mRNAs, 22 tRNAs,
and 2 rRNAs. A mtDNA with
a common deletion (ΔmtDNA;
right) introduced in mito-miceΔ
is 11.3 kbp in size, because 13
genes, including 7 mRNAs and 6
tRNAs (arc) are lost by a deletion.
Single capitals in maps indicate
tRNA genes. (B) Frequency of
neonatal death in mito-miceΔ car-
rying 1–70% ΔmtDNA in their
tails. Neonates of mito-miceΔ
were classiﬁed into four groups
carrying 1–34% (n = 23), 35–
49% (n = 30), 50–59% (n = 42),
and 60–70% (n = 31) ΔmtDNA,
respectively, in their tails. Neo-
nates of wild-type B6 mice were
used as normal controls (n = 30).
(C–E) Life span of mito-miceΔ car-
rying 1–70% ΔmtDNA in their tails
was assessed for days 1 to 34.
Based on the observed frequency
of neonatal death in mito-miceΔ
(see panel B), neonates of mito-
miceΔ were classiﬁed into two
groups carrying 1–49% (n = 53)
(D) and 50–70% (n = 73) (E) ΔmtDNA in their tails, and the life span of each group was examined. The life span of wild-type B6 mice was also examined
as a normal control (n = 30) (C). Survival curves were compared between mito-miceΔ carrying 1–49% ΔmtDNA and wild-type B6 mice (P = 0.3054, log-rank
test) and between mito-miceΔ carrying 50–70% ΔmtDNA and wild-type B6 mice (P , 0.0001, log-rank test).
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Measurement of blood lactate concentration
For the measurement of blood lactate concentration, blood was
collected from the tail vein of nonfasted mice. Lactate concentration
was measured by using an automatic blood lactate test meter (Lactate
Pro, ARKRAY, Kyoto, Japan).
Cytologic and histologic analysis
Blood samples were smeared on glass slides, and inclusions in reticulocytes
were visualized by staining with new methylene blue. Cells with granular
network inclusions that are a typical structure of reticulocytes were counted
(see open arrowheads in Figure 3D) and proportion of these reticulocytes
to 1000 red blood cells was estimated. The proportion of reticulocytes in
blood samples of mito-miceΔ and age-matched controls was measured. To
detect the accumulation of ferric iron, parafﬁn-embedded sections (5-mm
thick) of liver samples were stained with Prussian blue and then Safranin O
was used as a counter-staining. Eye samples were ﬁxed in Bouin’s solution,
and parafﬁn-embedded sections (8-mm thick) of the samples were stained
with hematoxylin and eosin.
Electron microscopic observation of
cytochrome c oxidase (COX) activity
An electron microscopic analysis of COX activity was performed as
described previously (Nakada et al. 2001; Seligman et al. 1968) with
slight modiﬁcations. To summarize, 25-mm cryosections of liver sam-
ples were ﬁxed in 2% w/v glutaraldehyde in phosphate-buffered saline
for 5 min at 0. Ultrathin sections, which were not stained with uranyl
acetate or lead nitrate solutions, were viewed directly on a transmission
electron microscope (model H-7650, Hitachi High-Technologies Cor-
poration, Tokyo, Japan). In this analysis, enzymatic activity of COX
was visualized as a black color (high electron density).
Statistics
The Student’s t-test was used to compare groups of data. All values are
presented as means6 SD. The log-rank test was used to compare survival
curves. P , 0.05 was considered to indicate statistical signiﬁcance.
RESULTS
Frequency of early death in mito-miceD
We ﬁrst examined the early life spans (1–34 days after birth) of mito-
miceΔ carrying 1–70% ΔmtDNA in their tails (n = 126). The pro-
portion of ΔmtDNA in individual mito-miceΔ was deduced from that
in their tails just after birth (day 0). In this assay, we also used wild-
type B6 mice as a normal control (n = 30). Approximately 20% of
wild-type B6 neonates died on day 1 after birth (Figure 1B), but none
died from days 2 to 34 (Figure 1C). The early life spans of mito-miceΔ
carrying ,50% ΔmtDNA in their tails were similar to those of wild-
type B6 mice (Figure 1, C and D). In contrast, when the ΔmtDNA
load in the neonates’ tails was$50%, the frequency of death on day 1
after birth was deﬁnitely increased compared with that of wild-type B6
mice (Figure 1B). The mito-miceΔ carrying 50–70% ΔmtDNA in their
tails continued to die after day 1, and only 34% of these neonates
survived until day 34 after birth (Figure 1E).
Although the aforementioned results indicated that most mito-
miceΔ carrying $50% ΔmtDNA died early (#34 days after birth),
a substantial proportion of the progeny of mothers carrying .33%
ΔmtDNA died very early (day 1 after birth; Figure 2A). Thus, it was
unclear that early death was associated with the proportion of
ΔmtDNA either in neonates or mothers. If the latter were the case,
then the frequency of early death of pups would be expected to in-
crease with the age of the mother, because ΔmtDNA accumulates in
various somatic tissues but disappears in eggs with time (Sato et al.
2007). Therefore, we next examined the frequency of early death in
the ﬁrst and second litters of three female mito-miceΔ carrying 28%
(Mouse 28), 52% (Mouse 52), and 61% (Mouse 61) ΔmtDNA, re-
spectively, in their tails just after birth. As expected, the proportion of
ΔmtDNA was much greater in the ﬁrst litter than the second litter
(Figure 2B). The rate of early death of pups was greatly and signiﬁ-
cantly greater in the ﬁrst litter than in the second delivery (Figure 2, B
and C; P , 0.05). The proportion of surviving pups from the second
litter (Figure 2C) was comparable with that of pups with wild-type B6
mothers (Figure 1B), despite the ΔmtDNA load of the mothers’ tails
increasing with time. Average loads of ΔmtDNA in tail samples were
32.4 6 21.9% (mean 6 SD) and 57.4 6 16.8% in live and dead mito-
miceΔ pups, respectively. On the basis of these results, we concluded
that early death of mito-miceΔ was caused by ΔmtDNA load in neo-
nates but not in mothers.
Phenotypic observations of late-stage embryos
of mito-miceD
To clarify the reason for the frequent early death in progeny carrying
$50% ΔmtDNA in their tails, we examined clinical phenotypes in
embryos at embryonic day 18.5 (E18.5), which is just 1 day before
birth. We obtained 55 E18.5 embryos carrying 35–70% ΔmtDNA in
Figure 2 Relationship between
early death and ΔmtDNA load
in mito-miceΔ. (A) Comparison
of ΔmtDNA proportion in tail
samples from pups and mothers.
Open circles and red crosses
indicate pups that were alive
and dead, respectively, at 34
days after birth. (B) Comparison
between ﬁrst and second litters
in terms of pup survival and
ΔmtDNA proportion in the tails
of pups. Three female mito-miceΔ
carrying 28% (Mouse 28), 52%
(Mouse 52), and 61% (Mouse 61) ΔmtDNA in their tails just after birth (day 0) were used in this assay. Open circles and red crosses indicate the
proportions of ΔmtDNA in the tails of pups that were alive and dead, respectively, at 34 days after birth. Blue symbols indicate the proportions of
ΔmtDNA in mother’s tails. (C) Comparison between the ﬁrst and second deliveries in terms of survival rates of pups from Mouse 28, Mouse 52, and
Mouse 61 at day 34 after birth. Data are presented as mean6 SD. Asterisk indicates signiﬁcant differences (P , 0.05).
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their tails. We also examined 55 E18.5 embryos from wild-type B6
mice as a normal control. None of the E18.5 embryos of wild-type B6
mice showed lethal phenotypes. Among the E18.5 embryos from
mito-miceΔ, three (5.5%) showed lethal phenotypes, and their tails
carried 66%, 67%, and 70% ΔmtDNA, respectively, indicating that
embryonic lethal phenotypes were restricted to embryos carrying
a high load of ΔmtDNA. A typical example of an embryo with a lethal
phenotype is shown in Figure 3A (right side): the embryo was atro-
phied and discolored when compared with littermate embryos carry-
ing ,66% ΔmtDNA in their tails. However, there was no signiﬁcant
difference in littermate number between normal mice and mito-miceΔ
at E18.5 (Figure 3B). Thus, we concluded that the embryonic lethality
was a rare event that was difﬁcult to relate to the observation of
frequent early death in mito-miceΔ.
We then examined the relationship between body weight and
ΔmtDNA load in tails (Figure 3, A and C). The average body weight
of wild-type E18.5 embryos was 1.19 6 0.03 g (n = 7), and that of
E18.5 embryos carrying 34–47% ΔmtDNA (1.20 6 0.07 g, n = 8) was
in the normal range. In contrast, a substantially lower body weight was
seen in E18.5 embryos carrying 52–66% ΔmtDNA (1.056 0.13 g, n =
14, P , 0.05). Thus, growth retardation was induced preferentially in
E18.5 embryos carrying $50% ΔmtDNA loads in tails, which was
associated with frequent early death after birth. It is well known that
ΔmtDNA is a genetic candidate for involvement in the pathogenesis
of PS, which is a rapidly fatal disorder of infancy characterized mainly
by sideroblastic anemia (DiMauro and Garone. 2011). Our results
suggested the possibility that neonates carrying $50% ΔmtDNA
may show clinical phenotypes of PS. We therefore examined whether
E18.5 embryos carrying $50% ΔmtDNA showed sideroblastic ane-
mia. Typical sideroblasts were not observed in peripheral blood sam-
ples from E18.5 embryos carrying $50% ΔmtDNA. In contrast,
compared with normal E18.5 embryos, the number of reticulocytes
in peripheral blood samples from E18.5 embryos carrying $52%
ΔmtDNA showed a statistically signiﬁcant increase (Figure 3, D and
E; P , 0.05), although the increase was slight. The proportion of
reticulocytes in peripheral blood samples from E18.5 embryos carry-
ing#42% ΔmtDNA was similar to that in samples from normal E18.5
embryos (Figure 3, D and E). These data suggested abnormalities of
hematopoiesis and the resultant onset of mild anemia in E18.5 em-
bryos carrying $50% ΔmtDNA. Because abnormal iron metabolism
Figure 3 Phenotypic observations of late-stage embryos of mito-
miceΔ. All embryos were obtained at embryonic day 18.5. (A) Mor-
phological observation of late-stage embryos carrying 0–66%
ΔmtDNA in their tails, as indicated. The embryo carrying no ΔmtDNA
(left side) was a wild-type B6 control. The six embryos carrying
ΔmtDNA were obtained from a single mother. The weight of each
embryo is shown below the panel. (B) Comparison of littermate num-
ber. Average numbers of littermates from mothers carrying 0% (white),
1–32% (gray), or 33–63% (black) ΔmtDNA. Data are presented as mean6
SD. NS, not signiﬁcant. (C) Relationship between weight and
ΔmtDNA load in late-stage embryos carrying 0% (white), 34–47%
(gray), or 52–66% (black) ΔmtDNA. Data are presented as mean 6 SD.
Asterisks indicate signiﬁcant differences (P , 0.05). (D) Cytological
observation of peripheral blood samples from late-stage embryos.
Peripheral blood samples carrying 0%, 36%, and 59% ΔmtDNA, re-
spectively, were stained with new methylene blue. In this method,
reticulocytes, a type of immature red blood cells (RBC), are visualized
as cells with blue inclusions (open arrowheads). Scale bar, 10 mm. (E)
Average proportion of reticulocytes in total RBCs in peripheral blood
samples from late-stage embryos carrying 0% (white), 34–42% (gray),
or 52–65% (black) ΔmtDNA. Data are presented as mean 6 SD. Aster-
isks indicate signiﬁcant differences (P , 0.05). (F) Histologic observa-
tions of iron metabolism in liver samples from late-stage embryos.
Liver samples carrying 0%, 41%, and 55% ΔmtDNA, respectively, were
stained with Prussian blue. In this method, abnormal iron metabolism
is visualized as blue deposits. Scale bar, 10 mm. (G) and (H) Electron
microscopic observation of COX activity in liver samples from late-
stage embryos. Mitochondria in hepatocytes and blood cells are
shown as (G) and (H), respectively. Arrows indicate mitochondria that
appeared normal in shape and COX activity, open arrowheads indi-
cate COX-deﬁcient mitochondria, and the closed arrowheads indicate
swollen mitochondria with COX activity. N, nucleus. Scale bar, 1 mm.
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in liver is observed in cases of sideroblastic anemia and PS (Camaschella.
2008; Gurgey et al. 1996), we examined pathologic changes in liver
samples from E18.5 embryos carrying ΔmtDNA. Deposits of ferric
iron indicating abnormal iron metabolism were preferentially
observed in liver samples from E18.5 embryos with an increased
number of reticulocytes (Figure 3F). On the basis of these observations,
we concluded that $50% ΔmtDNA loads could cause PS-like pheno-
types in late-stage mouse embryos, although it was not a typical PS.
In our previous studies using mito-miceΔ, accumulation of ap-
proximately 70–80% ΔmtDNA loads in various tissues was necessary
Figure 4 Dynamics of the proportion of ΔmtDNA in
early life and phenotypic observations of mito-miceΔ.
(A) Dynamics of proportion of ΔmtDNA in affected (pe-
ripheral blood and liver) and nonaffected (kidney) tis-
sues at various time points up to and including day 34
after birth. White and black bars indicate populations of
mito-miceΔ carrying ,50% and $50% ΔmtDNA in tail
samples, respectively. The relative ratio is the propor-
tion of ΔmtDNA in the tissue tested relative to that in
the tail of the same individual at day 0 after birth. Data
are presented as mean 6 SD. Asterisks indicate sig-
niﬁcant differences (P , 0.05). NS, not signiﬁcant. (B)
Dynamics of the proportion of ΔmtDNA in peripheral
blood samples from single individuals during early life.
Red and blue symbols indicate cases where the pro-
portion of ΔmtDNA in peripheral blood samples in-
creased and decreased, respectively, between days
14 and 34 after birth. Asterisk indicates signiﬁcant dif-
ferences (P , 0.05). (C) Cytological observations of pe-
ripheral blood samples obtained from mito-miceΔ at
day 34 after birth. Peripheral blood samples carrying
0%, 38%, and 59% ΔmtDNA, respectively, were stained
with new methylene blue and reticulocytes (open
arrowheads) are visualized similar to Figure 3D. Scale
bar, 10 mm. (D) Average proportion of reticulocytes in
total RBC. Results for peripheral blood samples
obtained from mito-miceΔ carrying 0%, 7–38%, and
53–64% ΔmtDNA are shown as white, gray, and black
colors, respectively. Data are presented as mean 6 SD.
NS, not signiﬁcant. (E) Histologic observations of iron
metabolism in liver samples from mito-miceΔ at day 34
after birth. Liver samples carrying 0%, 38%, and 47%
ΔmtDNA, respectively, were stained with Prussian blue.
Scale bar, 10 mm. (F) COX-EM of liver samples obtained
from mito-miceΔ at day 34 after birth. The COX-EM of
liver samples carrying 0%, 25%, and 47% ΔmtDNA, re-
spectively, are shown. The loading of 47% ΔmtDNA was
the maximum in the liver samples that we examined at
day 34, because the proportion of ΔmtDNA in liver was
lower than that in tissues during early life. N, nucleus.
Bar, 2 mm.
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to induce mitochondrial respiration defects, such as deﬁciencies of
complex IV (COX) in mitochondrial respiratory chains, and the re-
sultant onset of various clinical phenotypes. In contrast, E18.5 embryos
showed clinical phenotypes, even when they carried $50% ΔmtDNA.
These results were expected that threshold for tolerance to accumula-
tion of ΔmtDNA in embryonic liver and blood cells would be lower
than that in other tissues. Because electron microscopic observations of
COX activity (COX-EM) can visualize COX activity in individual mi-
tochondria of single cells (Nakada et al. 2001; Seligman et al. 1968), we
next performed COX-EM with liver samples from E18.5 embryos
carrying various loads of ΔmtDNA. In liver samples carrying $50%
ΔmtDNA, we observed three types of mitochondria in a single cyto-
plasm of hepatocytes, mitochondrion that appeared normal in COX
activity (arrows in Figure 3G), a swollen mitochondrion with COX
activity (closed arrowhead in Figure 3G), and a COX-deﬁcient swollen
mitochondrion (open arrowhead in Figure 3G). In blood cells of liver
samples carrying $50% ΔmtDNA, heterogeneity of COX activity
within individual mitochondria was clearly visible (Figure 3H), al-
though swollen mitochondria were not observed. These observations
indicated that $50% ΔmtDNA loads could induce mitochondrial res-
piration defects in hepatocytes and blood cells of late-stage embryos. In
addition, there were no autophagic ultra-structures around abnormal
mitochondria in hepatocytes or blood cells (Figure 3, G and H), in-
dicating that that the COX-deﬁcient mitochondria were not eliminated
by the mitophagy, even when a single cytoplasm contained mitochon-
dria with different mitochondrial respiratory functions.
Changes of DmtDNA load and clinical phenotypes in
mito-miceD during early life
The results of the early life span assay described previously (see Figure
1E) clearly showed that there were two populations of neonates carrying
$50% ΔmtDNA in their tail; the ﬁrst population showed death phe-
notypes in the ﬁrst month after birth, probably due to PS-like pheno-
types; and the second population was able to escape early death. In
mito-miceΔ, genetic variation is restricted to the load of ΔmtDNA in
various tissues, so that phenotypes are strictly induced by the load of
ΔmtDNA in affected tissues. Considering the point, there was a possi-
bility that that the ΔmtDNA load decreased preferentially in the pe-
ripheral blood and liver of surviving neonates by around 1-month after
birth. To test this possibility, we examined ΔmtDNA load in affected
and nonaffected tissues of surviving neonates at various time points up
to and including day 34 after birth (Figure 4A). In this assay, we could
not trace the proportion of ΔmtDNA load in tissues from single neo-
nates, because we had to kill neonates to obtain tissue samples. Thus, we
estimated the proportion of ΔmtDNA in each sample relative to that in
the tail sample taken on day 0 after birth from the same subject. The
animals were analyzed as two subgroups deﬁned by the ΔmtDNA load
in the tail (i.e., ,50% and $50% ΔmtDNA). In kidney samples as
a nonaffected tissue, the relative ratios increased with time in both
subgroups, suggesting that the proportion of ΔmtDNA in the nonaf-
fected tissues increased independently of the ΔmtDNA load (Figure 4A,
P , 0.05). In peripheral blood, there were two distinct patterns de-
pendent on ΔmtDNA load. In neonates carrying ,50% ΔmtDNA in
their tails at day 0, the relative ratios increased with time and the pattern
was similar to that of kidney samples (P , 0.05). In neonates carrying
$50% ΔmtDNA in their tails at day 0, the relative ratios in peripheral
blood samples did not increase with time. The relative ratios in liver
samples from both subgroups did not increase with time. In the case of
liver samples from E18.5 embryos carrying $50% ΔmtDNA, however,
a signiﬁcant decrease of relative ratios was observed (P , 0.05).
To conﬁrm changes in ΔmtDNA load in peripheral blood within
same individuals, we collected peripheral blood samples from single
neonates carrying 7–64% ΔmtDNA, respectively, in their tails at day 0.
We calculated the proportion of ΔmtDNA in peripheral blood on day
34 after birth relative to that on day 14 after birth (Figure 4B). The
relative ratios in surviving neonates carrying ,50% ΔmtDNA in their
tails were .1 and particularly high in neonates carrying ,20%
ΔmtDNA in their tails. In contrast, neonates carrying $50%
ΔmtDNA in their tails showed relative ratios ,1. There was a signif-
icant difference between neonates carrying ,50% and $50%
ΔmtDNA in their tails (P , 0.05). These data indicate that the pro-
portion of ΔmtDNA in peripheral blood decreased at an early age (i.e.,
from days 14 to 34) when the proportion of ΔmtDNA in peripheral
blood was $50%.
Consistent with these results, abnormalities observed in peripheral
blood and liver samples of late-stage embryos (Figure 3, D–G) were not
detected on day 34 after birth (Figure 4, C–F). There was no signiﬁcant
difference in reticulocyte number between wild-type mice and mito-
miceΔ (Figure 4, C and D). Iron deposits that were seen in livers from
late stage embryos carrying $50% ΔmtDNA were not observed in the
livers carrying 47% ΔmtDNA, which was the maximum proportion of
ΔmtDNA observed on day 34 after birth (Figure 4E) because of the
decreased ΔmtDNA loads in liver. In COX-EM, abnormalities were not
observed in liver samples (Figure 4F). These ﬁndings indicate that the
decrease of ΔmtDNA loading proportion in peripheral blood and liver
of neonates carrying $50% ΔmtDNA would be one reason for recov-
ering from PS-like phenotypes and for the resultant survival.
Disease phenotypes of surviving neonates when they
reach middle life
At 6 months of age or later, all the surviving mito-miceΔ showed lactic
acidosis, heart block, renal failure, male infertility, deafness, and
Figure 5 Phenotypic observations of middle-aged
mito-miceΔ. Histological observations of retina from
mito-miceΔ assayed at 6 months of age. Sections of
eye samples were stained with hematoxylin and eosin.
The proportion of ΔmtDNA in eye samples from the
opposite side is indicated under the each picture. Scale
bar, 50 mm.
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abnormalities in long-term memory as reported previously, when the
proportion of ΔmtDNA in affected tissues reached approximately 70–
80% (Inoue et al. 2000; Nakada et al. 2001, 2004, 2006; Ogasawara et al.
2010; Tanaka et al. 2008). In some of surviving mito-miceΔ carrying
.80% ΔmtDNA, retinal abnormalities were observed (Figure 5). These
results indicated that neonates that remitted from PS-like phenotypes in
early life expressed KSS-like phenotypes in their middle life.
DISCUSSION
Taking the current results together with our previous ones, we
summarized the development of mitochondrial diseases in mito-
miceΔ (Figure 6). On the basis of the difference in ΔmtDNA loads and
the resultant mitochondrial disease phenotypes, mito-miceΔ popula-
tion is classiﬁed into four subgroups. The ﬁrst subgroup was mito-
miceΔ carrying #10% ΔmtDNA at the birth. They showed normal
phenotypes because ΔmtDNA loads did not reach .70–80% in var-
ious tissues through the life (Normal subgroup in Figure 6). The
second subgroup was mito-miceΔ carrying 11–49% ΔmtDNA just
after birth, and the mice appeared healthy until middle age (6 months)
or later, but when the ΔmtDNA load reached .70–80% in various
tissues, they expressed KSS-like phenotypes (late-onset subgroup in
Figure 6). The main clinical features in this subgroup, such as low
body weight, lactic acidosis, heart block, renal failure, deafness, male
infertility, and abnormal long-term memory, has been reported pre-
viously (Inoue et al. 2000; Nakada et al. 2001, 2004, 2006; Ogasawara
et al. 2010; Tanaka et al. 2008). The third and fourth subgroups were
mito-miceΔ carrying $50% ΔmtDNA just after birth. When the
ΔmtDNA load in late-stage embryos reached $50%, abnormalities
of hematopoiesis and iron metabolisms in liver were induced, thus
leading to PS-like phenotypes (i.e., abnormalities in hematopoiesis
and iron metabolism; Figure 3, D–F), although .70–80% ΔmtDNA
loads were necessary for the onset of KSS-like phenotypes in adult
mito-miceΔ. Half of those expressing PS-like phenotypes died in early
life (#34 days after birth). The third subgroup, therefore, was the case
of onset of PS-like phenotypes and the resultant early death (early-
onset and death subgroup in Figure 6). The rest escaped from the
early death, because PS-like phenotypes in them disappeared consis-
tent with a decrease of ΔmtDNA load in affected tissues (see Figure 4,
D and E for the cases of peripheral blood and liver samples, respec-
tively). However, they expressed KSS-like phenotypes, when ΔmtDNA
load reached .70–80% in affected tissues (Figure 5). Thus, the fourth
subgroup was the case of transient onsets of PS-like and KSS-like
phenotypes in early and middle age, respectively, in a single mito-
miceΔ (Early-and late-onsets subgroup in Figure 6).
Heterogeneous distribution of mitochondria with and without COX
activity in single cells would be important for elucidating the reason
why the pathogenic threshold load of ΔmtDNA in embryonic blood
and liver was lower than that in other tissues. We have previously
reported that a uniform distribution of mitochondria either with or
without COX activity occurs in somatic cells of adult mito-miceΔ,
irrespective of whether the tissues contain low or high loads of
ΔmtDNA (Nakada et al. 2001). This ﬁnding indicates the occurrence
of mitochondrial genetic complementation in which individual mito-
chondria exchange gene products derived from mtDNA through their
fusion and ﬁssion. Because mitochondria carrying ΔmtDNA can be
supplied by mitochondria carrying wild-type mDNA, tissues carrying
ΔmtDNA did not show mitochondrial respiration defects until
ΔmtDNA accumulated to a level of .70–80%. In contrast, here we
observed that blood cells and hepatocytes in late-stage embryos showing
PS-like phenotypes contained mitochondria with heterogeneous ultra-
structures and COX activity levels (Figure 3, G and H). This ﬁnding
suggested the existence of deﬁciencies of mitochondrial fusion or ﬁssion
or both, and a lack of mitochondrial genetic complementation in these
late-stage embryonic cells. Such deﬁciencies could be one reason that
a load of $50% ΔmtDNA could cause pathogenicity in blood cells and
hepatocytes of late-stage embryos, whereas a higher load is required in
adult mice. Moreover, it has been reported that mitochondrial dynam-
ics, a continuous mitochondrial fusion and ﬁssion, is necessary to main-
tain normal mitochondrial respiratory function in mammals (Chen
et al. 2010; Ishihara et al. 2009). Therefore, it is possible that deﬁciencies
of mitochondrial dynamics and genetic complementation in embryonic
blood cells and hepatocytes enhance the pathogenicity of ΔmtDNA in
the case of a $50% ΔmtDNA load.
PS-like phenotypes induced by the abnormalities of hematopoiesis
and iron metabolisms in livers of late-stage embryos carrying $50%
ΔmtDNA were the main clinical features, but it is unclear why a half of
the neonates carrying $50% ΔmtDNA died early. There are several
possible explanations for this phenomenon. The ﬁrst is that the pups
might have suffered acute oxidative stress because newborns and infants
are particularly prone to oxidative stress (Saugstad 2005). Newborns
and infants have reduced antioxidant defense mechanisms as well as
high levels of free iron, which are required for the Fenton reaction
(Saugstad 2005); approximately 20% neonates died on day 1 after birth
even in wild-type B6 mice (Figure 1, B and C). Because neonates
Figure 6 Schematic represen-
tation of disease phenotypes in
mito-miceΔ population. “Normal”
and “late-onset” subgroups in
mito-miceΔ population and their
clinical features have already
been reported as our previous
studies (Inoue et al. 2000; Nakada
et al. 2001, 2004, 2006;Ogasawara
et al. 2010; Tanaka et al. 2008).
The novelty of this study was
to found out two subgroups,
“early-onset and death” and
“early- and late-onsets” in
addition of conventional two
subgroups, “normal” and “late-
onset” subgroups.
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carrying $50% ΔmtDNA in their tails possessed iron deposits in liver
(Figure 3F), the high level of iron could promote the Fenton reaction,
resulting in additional oxidative stress when the neonates are exposed to
a high oxygen concentration after delivery (Singer and Muhlfeld 2007).
Another possibility was that abnormalities in metabolic adaptation to
the aerobic condition just after birth might cause frequent early death in
mito-miceΔ. Anaerobic glycolysis is the major source of cellular ATP in
fetal tissues. In cells with mitochondrial respiration defects as the result
of pathogenic mutant mtDNAs, glycolysis is enhanced as a compensa-
tory mechanism to maintain ATP levels. Therefore, ΔmtDNA might
not demonstrate its pathogenicity in various cells during embryogenesis.
Supporting this notion, we observed only rare incidents of embryonic
lethality in mito-miceΔ. After birth, neonates carrying ΔmtDNA have to
change from anaerobic to aerobic energy metabolism in various cells as
soon as possible, but they would ﬁnd this process difﬁcult due to their
systemic and chronic mitochondrial respiration defects.
In summary, our model mouse study showed that a single
ΔmtDNA molecule has a pathogenic potential to cause PS-like and
KSS-like phenotypes at early and middle life, respectively, and also
suggested that difference in threshold for tolerance to accumulation of
ΔmtDNA in affected tissues between young infants and adults was
a possible reason for the onset of disease phenotypes in mito-miceΔ.
In addition, dynamics of ΔmtDNA load in affected tissues well cor-
related with the transition of disease phenotypes in mito-miceΔ. At
this sage, we considered that decreased proportion of ΔmtDNA in
peripheral blood and liver from young infants carrying .50%
ΔmtDNA was important to recover from PS-like phenotypes. How-
ever, we could not rule out a possibility that the decreased proportion
of ΔmtDNA in affected tissues was a result by which young infants
carrying .50% ΔmtDNA recovered from PS-like phenotypes. There-
fore, biological and clinical signiﬁcance of ΔmtDNA dynamics asso-
ciating with changes of disease phenotypes remains to be answered.
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